A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
一项随机 II 期研究,评估新辅助卡铂和紫杉醇联合或不联合阿特珠单抗治疗三阴性乳腺癌 (TNBC) 的疗效 - NCI 10013
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-022-00500-3
Ademuyiwa, Foluso O; Gao, Feng; Street, Cherease R; Chen, Ina; Northfelt, Donald W; Wesolowski, Robert; Arora, Mili; Brufsky, Adam; Dees, E Claire; Santa-Maria, Cesar A; Connolly, Roisin M; Force, Jeremy; Moreno-Aspitia, Alvaro; Herndon, John M; Carmody, Madelyn; Davies, Sherri R; Larson, Sarah; Pfaff, Kathleen L; Jones, Stephanie M; Weirather, Jason L; Giobbie-Hurder, Anita; Rodig, Scott J; Liu, Zheng; Hagemann, Ian S; Sharon, Elad; Gillanders, William E